Evidence map›Paper›PMID 19593403›Full record

ArticleMolecular medicine (Cambridge, Mass.)

The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE.

Mauricio Rosas-Ballina, Richard S Goldstein, Margot Gallowitsch-Puerta, Lihong Yang, Sergio Iván Valdés-Ferrer, Nirav B Patel, Sangeeta Chavan, Yousef Al-Abed, Huan Yang, Kevin J Tracey

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 193 citations in OpenAlex.

  1. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mauricio Rosas-BallinaLaboratory of Biomedical Science, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America.
Richard S Goldstein
Margot Gallowitsch-Puerta
Lihong Yang
Sergio Iván Valdés-Ferrer
Nirav B Patel
Sangeeta Chavan
Yousef Al-Abed
Huan Yang
Kevin J Tracey
Feinstein Institute for Medical Research · US

Funding

MACROPHAGE INACTIVATION IN SEPSIS AFTER TRAUMA OR SHOCKR01GM057226 · NIGMS · NORTH SHORE UNIVERSITY HOSPITAL · PI TRACEY, KEVIN J · 1999 to 2015
$5.5M
NIGMS NIH HHS R01 GM057226
6 · The paper itself

Abstract

The cholinergic antiinflammatory pathway modulates inflammatory cytokine production through a mechanism dependent on the vagus nerve and the alpha7 subunit of the nicotinic acetylcholine receptor. GTS-21 [3-(2,4-dimethoxybenzylidene) anabaseine], a selective alpha7 agonist, inhibits inflammatory cytokine production in murine and human macrophages and in several models of inflammatory disease in vivo, but to date its antiinflammatory efficacy in human monocytes has not been characterized. We report here our findings that GTS-21 attenuates tumor necrosis factor (TNF) and interleukin 1beta levels in human whole blood activated by exposure to endotoxin. GTS-21 inhibited TNF production in endotoxin-stimulated primary human monocytes in vitro at the transcriptional level. The suppressive effect of GTS-21 was more potent than nicotine in whole blood and monocytes. Furthermore, GTS-21 attenuated TNF production in monocytes stimulated with peptidoglycan, polyinosinic-polycytidylic acid, CpG, HMGB1 (high-mobility group box 1 protein), and advanced glycation end product-modified albumin. GTS-21 decreased TNF levels in endotoxin-stimulated whole blood obtained from patients with severe sepsis. These findings establish the immunoregulatory effect of GTS-21 on human monocytes, and indicate the potential benefits of further exploration of GTS-21's therapeutic uses in human inflammatory disease.

Indexed as

AdultAgedAged, 80 and overalpha7 Nicotinic Acetylcholine ReceptorBenzylidene CompoundsCells, CulturedCell SurvivalCholinergic AgonistsCytokinesEndotoxinsFemaleGene ExpressionHumansInterleukin-1betaMaleMiddle Aged3-(2,4-dimethoxybenzylidene)anabaseinealpha7 Nicotinic Acetylcholine ReceptorBenzylidene CompoundsCholinergic AgonistsChrna7 protein, humanCytokinesendotoxin, Escherichia coliEndotoxinsInterleukin-1betaNicotinePyridinesReceptor for Advanced Glycation End ProductsReceptors, ImmunologicReceptors, NicotinicToll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID19593403
PMCPMC2707516
OpenAlexW1542715374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.